Diabetes: Actions that change life
For AstraZeneca it is very important to educate doctors, patients and the general population about the correct management of this serious disease. We will be carrying out several activities that we want to share with all of you. Remember that together we have many measures in our hands to fight and prevent this disease. Together we can change our life with our daily actions!
463 million people
live with DIABETES in the world
200 million people
with CHRONIC KIDNEY
diseases in the world
17.7 million deaths
every year due to
40% of patients
with HEART FAILURE
have renal diseases
NUTRIPLANS FOR PATIENTS WITH DIABETES
Breakfasts, lunches, dinners and snacks of between 1,200 to 2,000 calories are included. All made and reviewed by expert nutritionists. Remember that together we have many measures in our hands to fight and prevent this disease. Together we can change our life with our daily
INNOVATION IN TREATMENTS FOR DIABETES TYPE 2
Diabetes is a disease characterized by high levels of glucose in the blood. Unfortunately it is a chronic disease; however, the patient can control it and avoid complications with proper treatment and care, achieving a better quality of life.
COMPARISON DAPAGLIFLOZIN VS SU,
DPP4 inhibitor and SGLT2 inhibitor
Learn about the differences between Dapagliflozin and other treatments and how they can help improve the lives of your patients. In this infographic you will find the difference between the use of Dapagliflozin vs other treatments. Diabetes is more than just glucose.
Produced by AstraZeneca CAMCAR Costa Rica S.A., Centro Corporativo Plaza Roble, Edificio Los Balcones, 2nd. floor, Escazú, San José, Costa Rica,.
phone: (506) 2201-3400, P.O. Box: 9931260 Escazú www.astrazeneca.com for AstraZeneca CAMCAR S.A. To report an adverse event please send an e mail to:
CC-4107 / December 2022
https://www.idf.org/aboutdiabetes/what-is-diabetes/facts-figures.html. Revisión 28 de Mayo 2020 World Health Organization. WHO World Heart Day 2017: Scale up prevention of heart attack and stroke: World Health Organization; 2017 [cited 2018 Jul 25]. Disponible en: http://www.who.int/cardiovascular_diseases/world-heart-day-2017/en/.
Ojo A. Addressing the global burden of chronic kidney disease through clinical and translational research. Trans Am Clin Climatol Assoc 2014; 125:229-43; discussion 243-6
International Diabetes Foundation. Diabetes Atlas Eighth Edition 2017 (p43). Available at https://www.idf.org/e-library/epidemiology-research/diabetes-atlas.html